These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21163819)

  • 21. Characterization of ocular and metastatic uveal melanoma in an animal model.
    Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF as a biomarker for metastatic uveal melanoma in humans.
    Barak V; Pe'er J; Kalickman I; Frenkel S
    Curr Eye Res; 2011 Apr; 36(4):386-90. PubMed ID: 21284506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
    Ma D; Luyten GP; Luider TM; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interferon status of patients with uveal melanoma].
    Likhvantseva VG; Slepova OS; Brovkina AF
    Vestn Oftalmol; 1999; 115(6):35-7. PubMed ID: 10665288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locoregional management of hepatic metastasis from primary uveal melanoma.
    Sato T
    Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
    Ben Simon GJ; Abulafia A; Pe'er J
    Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Introduction: Uveal melanoma.
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():7-19. PubMed ID: 19032677
    [No Abstract]   [Full Text] [Related]  

  • 30. [Assessment of serum GPC3 as a tumor marker for hepatocellular carcinoma and malignant melanoma].
    Komori H; Beppu T; Baba H; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():833-6. PubMed ID: 20960882
    [No Abstract]   [Full Text] [Related]  

  • 31. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.
    Deichmann M; Benner A; Waldmann V; Bock M; Jäckel A; Näher H
    J Exp Clin Cancer Res; 2000 Sep; 19(3):301-7. PubMed ID: 11144523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemoembolization of liver metastases in patients with uveal melanoma.
    Huppert PE; Fierlbeck G; Pereira P; Schanz S; Duda SH; Wietholtz H; Rozeik C; Claussen CD
    Eur J Radiol; 2010 Jun; 74(3):e38-44. PubMed ID: 19467811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers of therapeutic response in melanoma and renal cell carcinoma: potential inroads to improved immunotherapy.
    Kirkwood JM; Tarhini AA
    J Clin Oncol; 2009 Jun; 27(16):2583-5. PubMed ID: 19364958
    [No Abstract]   [Full Text] [Related]  

  • 34. Biomarker discovery from uveal melanoma secretomes: identification of gp100 and cathepsin D in patient serum.
    Pardo M; García A; Antrobus R; Blanco MJ; Dwek RA; Zitzmann N
    J Proteome Res; 2007 Jul; 6(7):2802-11. PubMed ID: 17539671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
    Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
    Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive power of screening tests for metastasis in uveal melanoma.
    Hicks C; Foss AJ; Hungerford JL
    Eye (Lond); 1998; 12 ( Pt 6)():945-8. PubMed ID: 10325992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
    Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment considerations for primary uveal melanoma with choroidal metastasis to the fellow eye.
    Bourla DH; Young TA
    Semin Ophthalmol; 2007; 22(3):175-7. PubMed ID: 17763240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.